The Oregon Supreme Court struck a petition after filings included AI‑generated fake citations, and a separate order imposed a $500 sanction while allowing a corrected response.

NSF is removing instruments from the Ocean Observatories Initiative, ending key below‑surface measurements off the Pacific Northwest as El Niño approaches.

A Portland startup says it preserved a whole pig brain at cellular resolution and will offer the procedure to terminally ill patients in Oregon. The work raises legal and ethical questions about timing, consent and what "revival" would mean.

Portland State chemists report T111 cleared malaria stages in lab and animal tests, suggesting a single‑encounter cure could be possible.

Lawmakers in Salem and city officials in Hillsboro have moved to pause data‑center tax breaks as polls and local opposition pile up, derailing planned projects. The dispute is reshaping where AI companies can build.

CompTIA sees a slight rebound for Portland's tech workforce in 2026 after two years of decline, with AI and data roles leading hiring.

Hillsboro-based Lattice is buying AMI for about $1.65B, adding firmware and datacenter manageability as it pushes toward a $1B revenue run rate.

Panthalassa raised $140M to finish a Portland pilot factory and build wave‑powered Ocean‑3 nodes that run AI at sea.

Oregon State researchers link routine generative AI use to weaker reflection and critical thinking in STEM students. The study recommends curricular fixes to rebuild reasoning skills.

A federal magistrate dismissed a family lawsuit over Valley View Winery after court briefs relied on fabricated legal citations, and lawyers were ordered to pay six‑figure costs.

OHSU researchers mapped a serotonin-linked brain circuit that can trigger phantom ringing in mice, suggesting why some antidepressants may worsen tinnitus.

Eagle Nuclear says the Aurora site near McDermitt, Oregon contains roughly 37 million pounds of uranium and has begun permitting and drilling planning.

OSU researchers combined nanoparticles and low‑power near‑infrared light to ablate melanoma tumors in mice; human testing remains a future step. The approach could be a less‑invasive alternative to wide excisions.